述评

非小细胞肺癌新分期对临床实践的影响

展开
  • 上海交通大学附属胸科医院肺内科, 上海 200030
韩宝惠(1961—), 主任医师, 博士, 博士生导师;电子信箱: xkyyhan@gmail.com。

网络出版日期: 2011-03-29

Impact of new staging of non-small cell lung cancer on clinical practice

Expand
  • Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China

Online published: 2011-03-29

摘要

肺癌TNM分期是指导临床实践的标准。UICC/IASLC于2009年公布的第7版肺癌分期较第6版肺癌TNM分期有较大的变动,主要是根据81 015例肺癌随访的结果对T分期和M分期进行了重新修订,新分期更能与肺癌的生存曲线相一致。该文就新分期的主要内容及对临床实践的可能影响进行了综述。

本文引用格式

韩宝惠, 孙加源 . 非小细胞肺癌新分期对临床实践的影响[J]. 上海交通大学学报(医学版), 2011 , 31(3) : 253 . DOI: 10.3969/j.issn.1674-8115.2011.03.001

Abstract

TNM staging of lung cancer serves as standard to guide clinical practice. There are greater changes in TNM staging from the six edition to the seventh edition published in 2009 by UICC/IASLC. T staging and M staging are revised in the seventh edition of TNM staging based on the findings from the follow-up of 81 015 cases of lung cancer. The seventh edition of TNM staging is more consistent with the survival curves of lung cancer. In this paper, the main contents of the seventh TNM staging and the possible impact on clinical practice are introduced.

文章导航

/